Colfax Corp (NYSE:CFX) SVP Jason Maclean sold 1,120 shares of Colfax stock in a transaction that occurred on Thursday, November 8th. The stock was sold at an average price of $29.06, for a total transaction of $32,547.20. Following the completion of the transaction, the senior vice president now directly owns 9,716 shares in the company, valued at approximately $282,346.96. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Shares of CFX traded down $0.64 during midday trading on Friday, hitting $28.09. The stock had a trading volume of 1,322,059 shares, compared to its average volume of 1,107,171. Colfax Corp has a fifty-two week low of $26.25 and a fifty-two week high of $42.08. The stock has a market cap of $3.40 billion, a price-to-earnings ratio of 16.14, a PEG ratio of 0.96 and a beta of 1.56. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.83 and a quick ratio of 1.37.
Colfax (NYSE:CFX) last announced its earnings results on Thursday, October 25th. The industrial products company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.52 by $0.02. Colfax had a net margin of 3.03% and a return on equity of 6.97%. The company had revenue of $875.37 million during the quarter, compared to analysts’ expectations of $893.38 million. Analysts anticipate that Colfax Corp will post 2.25 earnings per share for the current year.
Several equities analysts have recently issued reports on CFX shares. Oppenheimer reaffirmed a “hold” rating on shares of Colfax in a research note on Monday, August 6th. Robert W. Baird reaffirmed a “buy” rating and issued a $38.00 price objective (up previously from $36.00) on shares of Colfax in a research note on Monday, August 6th. Barclays lifted their price objective on shares of Colfax from $29.00 to $30.00 and gave the stock an “underweight” rating in a research note on Wednesday, August 8th. Zacks Investment Research raised shares of Colfax from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a research note on Thursday, August 9th. Finally, Cowen raised shares of Colfax from a “market perform” rating to an “outperform” rating in a research note on Friday, August 17th. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $34.77.
COPYRIGHT VIOLATION NOTICE: This report was posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://baseballnewssource.com/2018/11/10/colfax-corp-cfx-svp-jason-maclean-sells-1120-shares-of-stock/2972224.html.
Colfax Company Profile
Colfax Corporation operates as a diversified industrial technology company worldwide. The company operates through Air and Gas Handling, and Fabrication Technology segments. The Air and Gas Handling segment designs, manufactures, and supplies heavy-duty centrifugal and axial fans, rotary heat exchangers, and gas compressors, as well as related products, systems, and services.
Featured Article: Average Daily Trade Volume – What You Need to Know
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.